Anticomplementary activity of equine whole IgG antivenoms: Comparison of three fractionation protocols

Toxicon

Volumn 45, Issue 1, 2005, Pages 123-128

  León, Guillermo ^a   Lomonte, Bruno ^a   Gutiérrez, José María ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Anticomplementary activity; Antivenom; CH 50; Early adverse reactions; IgG

Indexed keywords

AMMONIA; IMMUNOGLOBULIN G; OCTANOIC ACID; PROPIOLACTONE; VENOM ANTISERUM;

ANTIBODY TITER; ARTICLE; BOTHROPS ASPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENERGY YIELD; FRACTIONATION; HEATING; HETEROLOGOUS EXPRESSION; HORSE; IN VITRO STUDY; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; SNAKE; STATISTICAL SIGNIFICANCE; TOXICOLOGY; VALIDATION PROCESS;

ANIMALS; ANTIVENINS; CHEMICAL FRACTIONATION; COMPLEMENT ACTIVATION; CROTALID VENOMS; ERYTHROCYTES; HORSES; HUMANS; IMMUNOGLOBULIN G; ION EXCHANGE; OCTANOIC ACIDS; PROPIOLACTONE; RABBITS; SHEEP;

BOTHROPS ASPER; EQUIDAE; ORYCTOLAGUS CUNICULUS;

EID: 9744249493     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2004.07.025     Document Type: Article

References (29)

1. Y. Angulo, R. Estrada, and J.M. Gutiérrez Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom Toxicon 35 1997 81 90
2. S. Barandun, P. Kistler, F. Jeunet, and H. Isliker Intravenous administration of human γ-globulin Vox Sanguinis 7 1962 157 174
3. T. Burnouf, and M. Radosevich Reducing the risk of infection from plasma products: specific preventive strategies Blood Reviews 14 2000 94 110
4. J.L.C. Cardoso, H.W. Fan, F.O.S. Franca, M.T. Jorge, R.P. Leite, S.A. Nishioka, A. Avila, I.S. Sano-Martins, S.C. Tomy, M.L. Santoro, A.M. Chudzinski, S.C.B. Castro, A.S. Kamiguti, E.M.A. Kelen, M.H. Hirata, R.M.S. Mirandola, R.D.G. Theakston, and D.A. Warrell Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in Sao Paulo, Brazil Quarterly Journal of Medicine 86 1993 315 325
5. 2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon Transactions of the Royal Society of Tropical Medicine and Hygiene 92 1998 657 662
6. R.C. Dart, and J. McNally Efficacy, safety and use of snake antivenoms in the United States Annals of Emergency Medicine 37 2001 181 188
7. M. García, M. Monge, G. León, S. Lizano, E. Segura, G. Solano, G. Rojas, and J.M. Gutiérrez Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation Biologicals 30 2002 143 151
8. I.B. Gawarammana, S.A.M. Kularatne, W.P. Dissanayake, R.P.V. Kumarasiri, N. Senanayake, and H. Ariyasena Parallel infusion of hydrocortisone ± chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites. A randomized, double-blind, placebo-controlled study Medical Journal of Australia 180 2004 20 23
9. 2 antivenoms. An example: new polyvalent European viper antivenom (equine) C. Bon M. Goyffon Envenomings and Their Treatments, Fondation Marcel Mérieux, Lyon 1996 161 172
10. R. Guidolin, J.F. Morais, M.A. Stephano, J.R. Marcelino, I.K. Yamaguchi, and H.G. Higashi Effect of β-propiolactone treatment on the complement activation mediated by equine antisera Revista Instituto de Medicina Tropical de Sao Paulo 39 1997 119 122
11. J.M. Gutiérrez Clinical toxicology of snakebite in Central America J. Meier J. White Handbook of Clinical Toxicology of Animal Venoms and Poisons 1995 CRC Press Florida 645 665
12. R.G.A. Jones, and J. Landon A protocol for 'enhanced pepsin digestion': a step by step method for obtaining pure antibody fragments in high yield from serum Journal of Immunological Methods 275 2003 239 250
13. T.W. Jungi, M. Santer, P.G. Lerch, and S. Barandun Effect of various treatments of gamma-globulin (IgG) for achieving intravenous tolerance on the capacity to interact with human monocyte Fc receptors Vox Sanguinis 51 1986 18 26
14. D.G. Lalloo, and R.D.G. Theakston Snake antivenoms Journal of Toxicology Clinical Toxicology 41 2003 277 290
15. 2 polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions Toxicon 39 2001 793 801
16. P. Malasit, D.A. Warrell, P. Chanthavanich, C. Viravan, J. Mongkolsapaya, B. Singhthong, and C. Supich Prediction, prevention, and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites British Medical Journal 292 1986 17 20
17. T.E. Mollnes, K. Hogasen, C. de Carolis, E. Vaquero, E.W. Nielsen, L. Fontana, and R. Perricone High-dose intravenous immunoglobulin treatment activates complement in vivo Scandinavian Journal of Immunology 48 1998 312 317
18. J. Montero, M. Trejos, and B. Lomonte Efecto del suero antiofídico sobre la actividad hemolítica del complemento humano (in vitro) y de conejo (in vitro e in vivo) Revista Costarricense de Ciencias Médicas 10 1989 1 9
19. 2 fragments Toxicon 32 1994 725 734
20. N.F. Moran, W.J. Newman, R.D.G. Theakston, D.A. Warrell, and D. Wilkinson High incidence of early anaphylactoid reaction to SAIMR polyvalent snake antivenom Transactions of the Royal Society of Tropical Medicine and Hygiene 92 1998 69 70
21. R. Otero, J.M. Gutiérrez, G. Rojas, V. Núñez, A. Díaz, E. Miranda, A.F. Uribe, J.F. Silva, J.G. Ospina, Y. Medina, M.F. Toro, M.E. García, G. León, M. García, S. Lizano, J. De La Torre, J. Márquez, Y. Mena, N. González, L.C. Arenas, A. Puzón, N. Blanco, A. Sierra, M.E. Espinal, M. Arboleda, J.C. Jiménez, P. Ramírtez, M. Díaz, M.C. Guzmán, J. Barros, S. Henao, A. Ramírez, U. Macea, and R. Lozano A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms Toxicon 37 1999 895 908
22. R. Otero-Patiño, J.L.C. Cardoso, H.G. Higashi, V. Núñez, A. Sierra, A. Díaz, M.F. Toro, M.E. García, A.M. Moreno, M.C. Medina, N. Castañeda, J.F. Silva-Díaz, M. Murcia, S.Y. Cárdenas, and W.D. Dias da Silva A randomized, blinded, comparative trial of one-pepsin digested and two whole IgG antivenoms for Bothrops snake bites in Urabá, Colombia American Journal of Tropical Medicine and Hygiene 58 1998 183 189
23. G. Rojas, J.M. Jiménez, and J.M. Gutiérrez Caprylic acid fractionation of hyperimmuine horse plasma: description of a rapid procedure for antivenom production Toxicon 32 1994 351 363
24. T. Saetang, N. Treamwattana, P. Suttijitpaisal, and K. Ratanabanangkoon Quantitative comparison on the refinement of horse antivenom by salt fractionation and ion-exchange chromatography Journal of Chromatography 700 1997 233 239
25. K. Schosinsky, M. Vargas, G. Vinocour, O.M. González, E. Brilla, and A. Gutiérrez Manual de Técnicas de Laboratorio. Química Clínica 1983 Universidad de Costa Rica San José p. 224
26. W. Stephan Undegraded human immunoglobulin for intravenous use Vox Sanguinis 28 1975 422 437
27. S.K. Sutherland Serum reactions. An analysis of commercial antivenoms and the possible role of anticomplementary activity in de-novo reactions to antivenoms and antitoxins Medical Journal of Australia 1 1977 613 615
28. K. Tanaka, E. Sawatani, G.A. Dias, E.M. Shigeoka, T.C.X.B. Campos, H.C. Nakao, and F. Arashiro High quality human immunoglobuin G purified from Cohn fractions by liquid chromatography Brazilian Journal of Medical and Biological Research 33 2000 27 30
29. R.D.G. Theakston, D.A. Warrell, and E. Griffiths Report of a WHO workshop on the standardization and control of antivenoms Toxicon 41 2003 541 557